Characteristics of apoptosis induction by the alkaloid emetine in human tumour cell lines

Planta Medica

Volumn 73, Issue 13, 2007, Pages 1389-1396

  Möller, Maren ^a   Wink, Michael ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Apoptosis; Bcl 2; Caspases; Emetine; p53 status; Proteomics

Indexed keywords

ALKALOID; CASPASE 3; CASPASE 6; CASPASE 8; CASPASE 9; EMETINE; LAMIN B; LAMIN B1; PLANT EXTRACT; PROTEIN BCL 2; PROTEIN P53; PSYCHOTRIA IPECACUANHA EXTRACT; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; RUBIACEAE; TUMOR CELL LINE;

ALKALOIDS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CEPHAELIS; DOSE-RESPONSE RELATIONSHIP, DRUG; EMETINE; FLOW CYTOMETRY; HUMANS; JURKAT CELLS; PHYTOTHERAPY;

PSYCHOTRIA IPECACUANHA; RUBIACEAE;

EID: 36048933416     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-990229     Document Type: Article

References (38)

1. Fulda S, Debatin KM. Exploiting death receptor signaling pathways for tumor therapy. Biochim Biophys Acta 2004; 1705: 27-41.
2. Herr I, Debatin KM. Cellular stress response and apoptosis in cancer therapy. Blood 2001; 98: 2603-14.
3. Wink M. Molecular modes of action of cytotoxic alkaloids - From DNA intercalation, spindle poisoning, topoisomerase inhibition to apoptosis and multiple drug resistance. In: Cordell G, editor. The Alkaloids New York, London: Academic Press; 2007: p xxxx.
4. Vedder EB. An experimental study of the action of ipecacuanha on amoeba. J Trop Med Hyg 1912; 15: 313-4.
5. Lewisohn R. Action of emetin on malignant tumors. JAMA 1918; 70: 9-10.
6. Panettiere F, Coltman CA Jr. Experience with emetine hydrochloride (NSC 33 669) as an antitumor agent. Cancer 1971; 27: 835-41.
7. Kane RC, Cohen MH, Broder LE, Bull MI, Creaven PJ, Fossieck BE Jr. Phase I - II evaluation of emetine (NSC-33669) in the treatment of epidermoid bronchogenic carcinoma. Cancer Chemother Rep 1975; 59: 1171-2.
8. Siddiqui S, Firat D, Olshin S. Phase II study of emetine (NSC-33 669) in the treatment of solid tumors. Cancer Chemother Rep 1973; 57: 423-8.
9. Moertel CG, Schutt AJ, Hahn RG, Reitemeier RJ. Treatment of advanced gastrointestinal cancer with ememtine (NSC-33669). Cancer Chemother Rep 1974; 58: 229-32.
10. Street EW. Cyclophosphamide plus emetine in lung cancer. Lancet 1972; 2: 381-2.
11. Mastrangelo MJ, Grage TB, Bellet RE, Weiss AJ. A phase I study of emetine hydrochloride (NSC 33669) in solid tumors. Cancer 1973; 31: 1170-5.
12. Bell DR. Treatment of amoebiasis. Trop Doct 1973; 3: 140-3.
13. Knight R. The chemotherapy of amoebiasis. J Antimicrob Chemother 1980; 6: 577-93.
14. Von Hoff DD, Rozencweig M, Soper WT. Whatever happened to NSC? An analysis of clinical results of discontinued anticancer agents. Cancer Treat Rep 1977; 61: 759-68.
15. Grollman AP, Huang MT. Inhibitors of protein synthesis in eukaryotes: tools in cell research. Fed Proc 1973; 32: 1673-8.
16. Grollman AP. Structural basis for inhibition of protein synthesis by emetine and cycloheximide based on an analogy between ipecac alkaloids and glutarimide antibiotics. Proc Natl Acad Sci USA 1966; 56: 1867-74.
17. Galasinski W, Chlabicz J, Paszkiewicz-Gadek A, Marcinkiewicz C, Gindzienski A. The substances of plant origin that inhibit protein biosynthesis. Acta Pol Pharm 1996; 53: 311-8.
18. Wink M. Evolution of secondary metabolites from an ecological and molecular phylogenetic perspective. Phytochemistry 2003; 64: 3-19.
19. Kochi SK, Collier RJ. DNA fragmentation and cytolysis in U937 cells treated with diphtheria toxin or other inhibitors of protein synthesis. Exp Cell Res 1993; 208: 296-302.
20. Bicknell GR, Snowden RT, Cohen GM. Formation of high molecular mass DNA fragments is a marker of apoptosis in the human leukaemic cell line U937. J Cell Sci 1994; 107: 2483-9.
21. Watanabe N, Iwamoto T, Dickinson DA, Iles KE, Forman HJ. Activation of the mitochondrial caspase cascade in the absence of protein synthesis does not require c-Jun N-terminal kinase. Arch Biochem Biophys 2002; 405: 231-40.
22. Beidler DR, Ahuja D, Wicha MS, Toogood PL. Inhibition of protein synthesis by didemnin B is not sufficient to induce apoptosis in human mammary carcinoma (MCF7) cells. Biochem Pharmacol 1999; 58: 1067-74.
23. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
24. Willingham MC. Cytochemical methods for the detection of apoptosis. J Histochem Cytochem 1999; 47: 1101-9.
25. Cossarizza A, Ceccarelli D, Masini A. Functional heterogeneity of an isolated mitochondrial population revealed by cytofluorometric analysis at the single organelle level. Exp Cell Res 1996; 222: 84-94.
26. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991; 139: 271-9.
27. Görg A, Postel W, Günther S. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 1988; 9: 531-46.
28. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
29. Havlis J, Thomas H, Sebela M, Shevchenko A. Fast-response proteomics by accelerated in-gel digestion of proteins. Anal Chem 2003; 75: 1300-6.
30. Möller M, Weiss J, Wink M. Reduction of cytotoxicity of the alkaloid emetine through P-glycoprotein (MDR1/ABCB1) in human Caco-2 cells and leukemia cell lines. Planta Med 2006; 72: 1121-6.
31. Evan G, Littlewood T. A matter of life and cell death. Science 1998; 281: 1317-22.
32. Broers JL, Bronnenberg NM, Kuijpers HJ, Schutte B, Hutchison CJ, Ramaekers FC. Partial cleavage of A-type lamins concurs with their total disintegration from the nuclear lamina during apoptosis. Eur J Cell Biol 2002; 81: 677-91.
33. Thiede B, Dimmler C, Siejak F, Rudel T. Predominant identification of RNA-binding proteins in Fas-induced apoptosis by proteome analysis. J Biol Chem 2001; 276: 26044-50.
34. Brockstedt E, Rickers A, Kostka S, Laubersheimer A, Doerken B, Wittmann-Liebold B et al. Identification of apoptosis-associated proteins in a human Burkitt lymphoma cell line. Cleavage of heterogeneous nuclear ribonucleoprotein A1 by caspase 3. J Biol Chem 1998; 273: 28057-64.
35. Gerner C, Frohwein U, Gotzmann J, Bayer E, Gelbmann D, Bursch W et al. The Fas-induced apoptosis analyzed by high throughput proteome analysis. J Biol Chem 2000; 275: 39018-26.
36. Wan J, Wang J, Cheng H, Yu Y, Xing G, Qiu Z et al. Proteomic analysis of apoptosis initiation induced by all-trans retinoic acid in human acute promyelocytic leukemia cells. Electrophoresis 2001; 22: 3026-37.
37. Verrills NM, Walsh BJ, Cobon GS, Hains PG, Kavallaris M. Proteome analysis of Vinca alkaloid response and resistance in acute lymphoblastic leukemia reveals novel cytoskeletal alterations. J Biol Chem 2003; 278: 45082-93.
38. Möller A, Soldan M, Völker U, Maser E. Two-dimensional gel electrophoresis: a powerful method to elucidate cellular responses to toxic compounds. Toxicology 2001; 160: 129-38.